Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00415649
What this trial is testing

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT04967508
What this trial is testing

Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisModerate to Severe Plaque Psoriasis
Samsung Bioepis Co., Ltd. 503
Post-approval studies (Phase 4)UnknownNCT05870618
What this trial is testing

Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children

Who this might be right for
Vaccine Reaction
Zhejiang Provincial Center for Disease Control and Prevention 480
Testing effectiveness (Phase 2)UnknownNCT05911048
What this trial is testing

A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 3,100
Large-scale testing (Phase 3)Study completedNCT01934140
What this trial is testing

Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination

Who this might be right for
Infections, Meningococcal
Pfizer 311
Early research (Phase 1)Looking for participantsNCT06366490
What this trial is testing

Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerRecurrent Epithelial Ovarian Cancer Which Includes Epithelial Ovarian, Fallopian Tube and/or Primary Peritoneal Cancer
PhotonPharma, Inc. 8
Large-scale testing (Phase 3)Study completedNCT00192491
What this trial is testing

Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children

Who this might be right for
Influenza
MedImmune LLC 1,200
Not applicableActive Not RecruitingNCT01527591
What this trial is testing

Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)

Who this might be right for
Infection in Solid Organ Transplant Recipients
University of California, Los Angeles 17
Testing effectiveness (Phase 2)Study completedNCT01026974
What this trial is testing

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine

Who this might be right for
Meningococcal Disease
Novartis Vaccines 120
Large-scale testing (Phase 3)Looking for participantsNCT07003984
What this trial is testing

A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.

Who this might be right for
Chikungunya Virus
Bavarian Nordic 720
Not applicableStudy completedNCT02819115
What this trial is testing

Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine

Who this might be right for
Influenza
Butantan Institute 63
Testing effectiveness (Phase 2)Study completedNCT03339713
What this trial is testing

Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF), With and Without Co-administration, in Adults Aged 60 Years and Older in Stable Health

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 180
Early research (Phase 1)Study completedNCT04634513
What this trial is testing

Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

Who this might be right for
Shigella InfectionEnterotoxigenic Escherichia Coli Infection
University of Maryland, Baltimore 53
Large-scale testing (Phase 3)Study completedNCT05083182
What this trial is testing

Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

Who this might be right for
Arthritis, Juvenile
Janssen Research & Development, LLC 48
Large-scale testing (Phase 3)WithdrawnNCT05534048
What this trial is testing

Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older

Who this might be right for
SARS-CoV-2 Infection
Everest Medicines (Singapore) Pte. Ltd.
Early research (Phase 1)Study completedNCT01446926
What this trial is testing

Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants

Who this might be right for
PneumoniaPneumococcal InfectionsStreptococcus Pneumoniae Infections
Sanofi Pasteur, a Sanofi Company 280
Post-approval studies (Phase 4)Study completedNCT01627340
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Who this might be right for
Hepatitis B
GlaxoSmithKline 667
Testing effectiveness (Phase 2)Study completedNCT01640691
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic Influenza
Adimmune Corporation 39
Early research (Phase 1)Study completedNCT01623518
What this trial is testing

A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1

Who this might be right for
Influenza
University of Oxford 15
Large-scale testing (Phase 3)Study completedNCT02079207
What this trial is testing

Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine

Who this might be right for
Pneumococcal Infections
SK Chemicals Co., Ltd. 767
Next Page